Skip to main content

and
  1. Article

    Open Access

    Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

    Monetizing health has sparked controversy and has implications for pricing strategies of emerging health technologies. Medical insurance payers typically set up thresholds for quality-adjusted life years (QALY...

    Qian Peng, Yue Yin, Min Liang, Mingye Zhao in Cost Effectiveness and Resource Allocation (2023)

  2. Article

    Open Access

    Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

    Non-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget impact o...

    Leyi Liang, Taihang Shao, Hao Li, Mingye Zhao, Wenxi Tang in BMC Public Health (2023)